-
Mashup Score: 12
This editorial refers to ‘Prognostic Significance of Hemodynamic Parameters in Patients with Cardiogenic Shock’, by D. D. Berg et al. https://doi.org/10.1093/eh
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 19Myocardial Bridging: Diagnosis, Functional Assessment, and Management: JACC State-of-the-Art Review - 7 month(s) ago
Abstract Myocardial bridging (MB) is a congenital coronary anomaly in which a segment of the epicardial coronary artery traverses through the myocardium for a portion of its length. The muscle over…
Source: www.jacc.orgCategories: Cardiologists1, Latest HeadlinesTweet
-
Mashup Score: 0Re-Architecting a Hemo System Using Behavioral Science - 10 month(s) ago
Behavioral science is being applied in unique ways for enterprise imaging product design. Involving clinicians in the product design process has led Change Healthcare to completely re-architect a new-generation hemodynamic solution. By listening to key stakeholders, new features are being brought to market that will have notable impact on the way health systems operate. By building better…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 11 Week to Register! Fixing Hemodynamic Instability Webinar - 11 month(s) ago
Moderator: Daniel J. Cole, MD, Professor of Clinical Anesthesiology, and Vice Chair for Professional and Business Development, Anesthesiology, University of California, Los Angeles, Los Angeles, CA Daniel J. Cole, MD, earned his Doctor of Medicine degree from Loma Linda University, where he also completed his residency in anesthesiology. He completed a neuroscience research fellowship at the…
Source: mailchi.mpCategories: Anesthesiology, Latest HeadlinesTweet
-
Mashup Score: 0New Data Show Remote Monitoring Technology Like Abbott’s Cardiomems Helps Improve Survival in Heart Failure Patients - 1 year(s) ago
March 24, 2023 — Abbott announced new data that found monitoring patients remotely with hemodynamic pressure sensing technology, such as with its CardioMEMS HF System, can significantly1 improve survival in heart failure patients with reduced ejection fraction (HFrEF). The analysis is the first to give doctors specific insight into how remotely monitoring patients with technology like CardioMEMS…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 6Program Guide | THT 2023 - 1 year(s) ago
Sign Up for Our NewsletterGet the latest news and information from CRF.By submitting your email address, you agree to CRF’s Privacy Policy & Terms and Conditions.1700 Broadway, 9th FloorNew York, NY 10019646.434.4500[email protected]© 2023, Cardiovascular Research Foundation. All rights reserved.Privacy PolicyTerms and Conditions of Use
Source: tht2023.crfconnect.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Program Guide | THT 2023 - 1 year(s) ago
Sign Up for Our NewsletterGet the latest news and information from CRF.By submitting your email address, you agree to CRF’s Privacy Policy & Terms and Conditions.1700 Broadway, 9th FloorNew York, NY 10019646.434.4500[email protected]© 2023, Cardiovascular Research Foundation. All rights reserved.Privacy PolicyTerms and Conditions of Use
Source: tht2023.crfconnect.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Hone your skills on how and why to perform invasive #hemodynamic exercise testing, and how to interpret the results for optimal phenotyping of #heartfailure. Tuesday, 3/21, 2:00 PM. Only at #THT2023! https://t.co/1N01wuRgKR @StavrosDrakos @JenHoCardiology @HFpEF @RyanTedfordMD… https://t.co/9nX26P4E0Z https://t.co/YpDHOKHhMK
-
-
Mashup Score: 0Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension - Cardiovascular Drugs and Therapy - 1 year(s) ago
Purpose Although classified as group 1 pulmonary arterial hypertension (PAH), patients with systemic sclerosis-related pulmonary hypertension (SSc-PH) experience poorer clinical response to PAH therapy and increased mortality compared to those with idiopathic PAH. Due to heterogeneity in phenotypes, identifying patients likely to respond to therapy is challenging. The goal of this study was to…
Source: SpringerLinkCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0
Selexipag improved pulmonary vascular resistance and other hemodynamic variables among patients with chronic thromboembolic pulmonary hypertension, according to results published in European Respiratory Journal.However, there was no change in exercise capacity after treatment.
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0
Selexipag improved pulmonary vascular resistance and other hemodynamic variables among patients with chronic thromboembolic pulmonary hypertension, according to results published in European Respiratory Journal.However, there was no change in exercise capacity after treatment.
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
Selexipag treatment improved pulmonary vascular resistance and other #hemodynamic variables in patients with CTEPH in randomized study published in @ERSpublications @CardiologyToday https://t.co/zGVU4UWFDm
-
New editorial, one question - what is next in #hemodynamic assessment of #CardShock https://t.co/RgjSu5DxeQ @krychtiukmd @drmilicaa @EHJACVCEiC @ACVCPresident @JohannesGrand @escardio #EHJACVC